Carme Pampín’s interview, the CEO of GalChimia and the president of Life Sciences Business Technology Cluster (BIOGA).
GalChimia came into being as a result of the entrepreneurial adventure undertaken by two doctors of organic chemistry at the University of Santiago, Professor Gabriel Tojo and Professor Ramón Estévez. They had identified a business opportunity thanks to their previous experience in research contracts within the industry providing the chance to find a professional outlet which was different to the traditional types and at the same time in line with their training and vocation.
Initially the idea was to become a high added value chemical products supplier to research laboratorios.
Thus, GalChimia consists of a highly qualified team, one which is highly motivated to move forward with the Project offering several services of interest for the pharmaceutical industry and research chemistry mainly.
In the last years the biopharmaceutical ecosystem in Galicia has gained importance and that has contributed to positioning the company as a technological pole for excellence. The technical solvency and professionalism of the Galican companies has been key in reaching this milestone. For any company, and also for GalChimia, it is important to feel part of a group and take advantage of the synergies and strengths of the community to gain outward visibility and also prestige as an innovative region.
As the president of the Life Sciences Technology Cluster in Galicia (Bioga), Carme Pampín thinks in Galicia it is undeniable that the sector is experiencing real growth, The main problem that companies have both in Galicia and Spain is the lack of financing to carry out certain business projects that require large investments, but in Galicia there are experts in getting more from less and in that sense there are initiatives which have been very successful despite the limited resources invested.
Moreover, collaboration with other companies allows GalChimia to establish collaborations with the field that 15 years ago would have been unthinkable. At the moment the company have at least 3 research projects underway with Galician companies, coming from such diverse sectors as canning, energy production and biopharmaceutical.